Out-licensing

Messenger Biopharma will not develop its own mRNA products.

We are eager to out-license our Aegis biotechnology to pharmaceutical and biotech companies for vaccine and gene therapy products development.

Last news

Jérôme Lemoine has invented a biotechnology platform to treat many…

posted February 15, 2016

“Jérôme Lemoine has invented a ...Read More